Background
==========

The risks associated with banked homologous blood products are well known. These risks include among others: ABO incompatibilities, viral or bacterial infections, and immunosuppression \[[@B1]\]. Immunomodulation may have long lasting effects on the patient who has received a single unit of homologous blood, and may alter the immune response in a way that may render the recipient vulnerable to infection \[[@B2]\]. Several techniques for management of surgical patients without homologous blood transfusion are available. Acute normovolaemic hemodilution (ANH) is the simultaneous exchange of whole blood with an identical volume of an iso-oncotic colloid. The resulting dilutional anaemia is compensated for by an increase in cardiac output and enhanced arterial oxygen extraction. Although bleeding during surgery remains essentially unchanged, blood lost during the surgical procedure contains fewer red cells because the patient\'s blood has been diluted. At the conclusion of surgery or when needed, donated blood may be returned to the patient \[[@B3]\]. ANH is found to be effective in surgical cases with a high-expected blood loss \[[@B4]\]. The concept of decreasing the arterial blood pressure to hypotensive levels during anaesthesia and surgery has been used for decades in attempt to reduce intraoperative blood loss and to improve conditions in the surgical field. A mean arterial blood pressure (MAP) of 55--60 mmHg has been regarded as the lowest safe level in young healthy patients, one of the reasons being that this range represents the lowest MAP at which auto regulation of the cerebral blood flow is still active.

Sharrock introduced the hypotensive epidural anaesthesia (HEA) in 1989 \[[@B5]\]. Epidural anaesthesia was used to establish a sympathetic blockade, causing a hypotensive state. Low dose of epinephrine was infused to maintain and stabilize cardiac output and heart rate. During HEA, a MAP of 45--50 mmHg was allowed since the cerebral condition could be monitored through the patient\'s ability to communicate, as only slight sedation was used. HEA is a safe technique with a low complication -- and mortality rate, even in patients with left ventricular dysfunction \[[@B6]-[@B8]\]. This method reduces blood loss and need for transfusions significantly in hip arthroplasty surgery \[[@B9]\]. We have in a previous paper demonstrated a reduced perioperative blood loss at 47 % in knee arthroplasty surgery (TKR) during HEA \[[@B10]\].

The aim of this study was to evaluate the potential benefits of a reduced need for homologous blood transfusion by combining HEA and ANH in TKR surgery.

Methods
=======

The study was approved by the regional scientific ethics committee and corresponds with the Helsinki II declaration. In all patients written informed consent was obtained.

Twenty-eight patients scheduled for primary cemented TKR surgery were included in the study period. Exclusion criteria were: Patients underage (\<18 years), hematocrit \< 0.30, recent myocardial infarction (\<6 months), unstable angina, diagnosed and clinical symptomatic aortic- or mitral valve stenosis (\>30 mmHg), previous stroke, unmedicated hypertension and treatment with beta-antagonists or anticoagulants. No patient was medicated with salicylate or nonsteroidal anti-inflammatory drugs in the two weeks prior to surgery.

On the day of surgery patients were consecutive and blindly randomised to HEA with or without ANH using computerised randomisation to two treatments (MedStat^®^).

ANH was performed by drawing 20 % of the total blood volume through a venous cannula immediately before anaesthesia. This volume was simultaneously replaced with an equal volume of Hydroxy Ethyl Starch 6 % (HAES 6 %). The following formula was used:

Total blood volume = body weight (kg) × 60 mL per kg.

The donated volume of blood was collected in transfusion bags together with a stabilizer. Until re-transfusion in the recovery room, the blood was storaged in a cooler box. Retransfusion was terminated within 6 hours. Both groups were anaesthetized with the hypotensive epidural anaesthesia technique.

HEA
---

To establish the sympathetic blockade, epidural anaesthesia was performed at the Th12-L1/L1-L2 interspace with ropivacaine 1%, 25--35 ml to achieve analgesia at Th1-2 dermatome. For epidural infusion, ropivacaine 1% 6--8 ml/h was used until end of surgery. The infused dose varied according to the patient\'s age, height and weight. The arterial pressure decreased progressively over 10 minutes after the epidural bolus injection to a MAP of 45--50 mmHg. In case of insufficient decrease in blood pressure, bolus ropivacaine 5 ml epidurally was used. Infusion of epinephrine 0.01--0.07 μg/kg/min was started immediately after insertion of the central vein catheter; in order to prime the catheter before the sympathetic blockade was established. During surgery sedation with propofol was adjusted to a level where communication was possible. Intraoperative infused fluid volume was in both groups isotonic saline 5 mL/kg/h as basic need and Isotonic saline three times the amount of blood loss as substitution for intraoperative blood loss. Oxygen was delivered at 3 l/min on a nasal catheter. All patients were kept warm, using a Bair-hugger. No knee tourniquet was used.

Monitoring: 5-lead ECG, pulse oximetry, respiratory rate, end-tidal CO2, radial- and central venous pressures. All data were continuously recorded on a computer, using the Datex Collect (software (Datex, Denmark).

Infusion of epinephrine was continued postoperatively until MAP reached 75 mmHg, hereafter epinephrine was reduced gradually until removal. In both groups, the intraoperative blood loss was determined by measurement of the volume in the suction apparatus, and by weighing of towels. The postoperative blood loss was determined by measuring the drainage for 48 hours after operation. Drains were removed after 48 hours.

Postoperative analgesia was performed as patient controlled epidural analgesia using ropivacaine 0.2 % and morphine 0.05 mg/ml for three days, according to our normal routine. The epidural catheter was removed on the third postoperative day. Hereafter the patients were treated orally with morphine and acetaminophen. Fragmin^®^ was given as thrombo-prophylaxis. All patients used a continuous passive knee motion apparatus the first two postoperative days.

The patients were anaesthetized by one of the three anaesthesiologist authors and operated by two surgeons. Demographics, hematocrit pre- and post ANH, at arrival at recovery room, and at 1., 2., 3., and 5. postoperative day were recorded. Intra- and postoperative fluid- and blood transfusions were also registered. Blood transfusion was indicated when the hematocrit value was below 28 %.

Statistics
----------

After passing through the exclusion criteria patients were consecutive and blindly randomised to HEA with or without ANH using computerised random numbers for 2 treatments (MedStat^®^). The result of the randomisation was known immediately before anaesthesia.

Data are presented as means (SD) or means (range). Comparison between groups was performed with a Student\'s t-test. For ASA-score a Mann Whitney\'s test was used. Chi-test was applied on gender and the fraction of transfused patients in the two groups. A p \< 0.05 was chosen as significance level.

The sample size of this study was determined by an expected effect of ANH on blood transfusion rate of 50 % (MIREDIF). α = 5 %, β = 10 %, SD = 400

n~1~ = n~2~ = 2(t~2(~ + t~β~)^2^SD^2^/MIREDIF^2^

Power = (1-β) = 1-0.10 = 0.90

This calculation resulted in 13 patients in each group. We decided to enrol 14 in each group.

Results
=======

In all 33 patients were screened to enter this study. Three patients were excluded because of treatment with beta-antagonists and 2 patients because of previous stroke.

Twenty-eight patients, 14 ANH and 14 non-ANH were enrolled in the study. Patient characteristics and preoperative blood measurements are shown in Table [1](#T1){ref-type="table"}. Except from the preoperative mean artery blood pressure (measured before blood donation) there was no significant difference in between groups. Intraoperative values are shown in Table [2](#T2){ref-type="table"}. The ANH group was given ropivacaine 1 %, mean 288 ± 32 mg and non-ANH ropivacaine 1 %, 297 ± 22 mg (ns). The intraoperative mean artery blood pressure was identical between groups. MAP demonstrated a reduction of 53.4 % (ANH) and of 58.4 % (non-NAH), compared to preoperative blood pressure (ns).

###### 

Demographics and preoperative measurements of the patients.

                                       ANH          Non-ANH      P
  ------------------------------------ ------------ ------------ ----------
  n                                    14           14           
  Sex, F/M                             10/4         11/3         1.00
  Age, yr                              75.8 (6.4)   70.1 (9.6)   0.08
  Weight, kg                           75 (11.5)    76 (13.2)    0.81
  Height, cm                           166 (8)      166 (10)     0.98
  ASA (median (range))                 2 (1--2)     2 (1--2)     0.75
  Mean arterial blood pressure, mmHg   103 (12)     118 (19)     0.02^\*^
  Total blood volume, mL               4471 (809)   4446 (736)   0.93

ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolaemic hemodilution; Mean (SD) ^\*^ significance

###### 

Perioperative values for the patients.

                                       ANH 14       Non-ANH 14   P
  ------------------------------------ ------------ ------------ ------
  Mean arterial blood pressure, mmHg   47.9 (1.8)   49.0 (3.6)   0.31
  Central vein pressure, mmHg          4.5 (2)      6.1 (4)      0.21
  Duration of surgery, min             93 (13)      100 (20)     0.26
  Duration of anaesthesia, min         182 (15)     193 (23)     0.16
  Duration of hypotension, min         102 (20)     110 (22)     0.34
  Core temperature after surgery, C    36.5 (0.4)   36.7 (0.7)   0.20
  Postoperative ICU-time, hrs          6.8 (1.2)    7.1 (0.8)    0.36

ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolaemic hemodilution; Mean (SD) ^\*^ significance

Postoperatively in the recovery room, MAP was below 75 mmHg for 38 min ± 40 (ANH) vs. 52 min ± 77 (non-ANH) (p = 0.56). Time used for anaesthesia (from patient enters the operating theatre to entering the recovery room) and duration of surgery was identical between groups. Core temperature on admission to the recovery room was also without a significant difference.

The preoperative donated blood volume was mean 877 mL ± 175, or 19.7 % of the total blood volume. All blood was retransfused to ANH patients in the recovery room.

Perioperative blood loss and substitution are shown in Table [3](#T3){ref-type="table"}. At almost all registrations there was a reduced blood loss in non-ANH group. Colloid substitution was in ANH group 679 mL and blood transfusion 386 mL, without including the infusion of HAES used in the ANH procedure and the predonated amount of blood. Fifty percent in the ANH group received homologous blood transfusion during the hospital stay (771 mL pr. patient transfused) vs. 42 % in non-ANH group (800 mL pr. patient transfused) (ns). Numbers of units packed red cells are shown in Table [4](#T4){ref-type="table"}. No patients received blood components other than erythrocytes.

###### 

Blood loss and substitution for the patients.

                                           ANH 14       Non-ANH 14   P
  ---------------------------------------- ------------ ------------ ----------
  Blood loss intraoperative, mL            131 (78)     111 (56)     0.45
  Blood loss 1. postop. Hour, mL           295 (129)    204 (77)     0.03^\*^
  Blood loss 2. postop. Hour, mL           192 (98)     118 (72)     0.03^\*^
  Blood loss 3. postop. Hour, mL           132 (85)     111 (61)     0.47
  Blood loss 24. postop hours, mL          1057 (292)   836 (280)    0.05^\*^
  Blood loss 2. postop day, mL             109 (78)     83 (67)      0.36
  Total blood loss, mL                     1306 (300)   1026 (294)   0.02^\*^
  Homologous blood transfusion (PRC), mL   386 (720)    343 (454)    0.85
  Crystalloid first 24 hours, mL           3229 (582)   3312 (731)   0.75
  Colloid first 24 hours, mL               679 (575)    377 (361)    0.12
  Donated amount of blood, mL              877 (175)                 

ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolaemic hemodilution; Mean (SD) ^\*^ significance

###### 

Patients receiving blood substitution (units of packed red cells).

                           ANH 14   Non-ANH 14   P
  ------------------------ -------- ------------ ------
  Zero                     7        8            
  1 unit                   4        0            
  2 Units                  1        4            
  3 Units                  1        0            
  \>3 Units                1        2            
  Average transfused, mL   386      343          0.85

ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolaemic hemodilution

The perioperative blood analysis demonstrated, except from hematocrit at start and conclusion of surgery, no differences (Table [5](#T5){ref-type="table"}).

###### 

Perioperative blood measurements.

                                          ANH 14     Non-ANH 14   P
  --------------------------------------- ---------- ------------ -----------
  Hematocrit preoperative, %              38.7 (3)   38.1 (5)     0.71
  Hematocrit at start of surgery, %       30.4 (5)   38.1 (5)     0.001^\*^
  Hematocrit 1. hour postop, %            28.7 (3)   32 (4)       0.04^\*^
  Hematocrit 1. postop day, %             29.8 (3)   29.9 (4)     0.91
  Hematocrit 2. postop day, %             30.7 (3)   29.9 (4)     0.63
  Hematocrit 3. postop day, %             30.4 (3)   28.8 (2)     0.14
  Hematocrit 5. postop day, %             29.4 (3)   30.3 (4)     0.53
  Platelet count preoperative, 10^6^/l    257 (72)   265 (63)     0.35
  Platelet count 1. postop day, 10^6^/l   190 (60)   185 (42)     0.81
  Platelet count 5. postop day, 10^6^/l   322 (85)   337 (77)     0.38
  APTT preoperative, sec                  32 (3)     30 (3)       0.16
  Creatinine preoperative, mol/L          83 (21)    85 (23)      0.79
  Creatinine 1. postop.day, mol/L         82 (20)    80 (17)      0.58
  Creatinine 5. postop day, mol/L         80 (22)    74 (13)      0.39

ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolaemic hemodilution; Mean (SD) ^\*^ significance

There was no difference in time spent in hospital between the groups. At the 7\'Th postoperative day all patients in this study were transferred to a hotel department for further mobilisation. During the hospital stay we did not observe any cases of renal failure according to the Creatinine measurements. All patients were discharged from the hospital alive.

Discussion
==========

In both groups there was a remarkable low total blood loss, due to the anaesthetic technique used (HEA). The blood loss was, especially the non-ANH group, in a range identical with the result of our previous study comparing HEA with normotensive regional anaesthesia in TKR surgery \[[@B10]\]. ANH failed in the present study to demonstrate a reduced need for blood transfusion with homologous blood products during TKR surgery in HEA anaesthesia. We here use a moderate hemodilution (20 % of total blood volume) to a hematocrit near 30% agreeing with the recommendations for patients at this age \[[@B11]\]. Despite of this 50% in the ANH group received homologous blood. In a previous ANH study without the use of HEA anaesthesia, 45 % of TKR patients received homologous blood \[[@B12]\]. A case study analysis of patients who had undergone moderate ANH (15 % of patients blood volume) estimated that only 0.5 unit of blood is \"saved\" \[[@B13]\]. Mathematical models concur that savings are small unless profound hemodilution is accompanied by large blood loss (\> 2 L) \[[@B14]\]. Another study postulates that the safety and efficacy of more extensive hemodilution is controversial because it is not possible for all patients and may provide only little additional blood conservation \[[@B15]\].

At almost all registrations the ANH group demonstrated an increased postoperative blood loss compared to the non-ANH group. Dilution of the blood after ANH is the most reasonable explanation to this. TKR surgery is known to be associated with extensive postoperative blood loss, probably because of difficulties in performing postoperative compression and haemostasis of the tissue in the knee \[[@B10]\]. This fact combined with the reduced viscosity of the blood could increase the postoperative blood loss. We did not register any difference in time spent in surgery or postoperative hypotension that could explain differences in the blood loss. In a previous study mild hypothermia was found to be correlated to a significantly increased blood loss in hip arthroplasty surgery \[[@B16]\]. We did not register differences in postoperative core temperature. Another possible explanation for the difference in blood loss could be alternation of the coagulation system because of the hemodilution. ANH is found to cause a slight coagulopathy including a decrease in platelet count, prothrombin time, fibrinogen, AT-III and plasminogen. Furthermore APTT is increased. The combination of ANH and prostaglandin E1 induced hypotension to 55 mmHg did not alter the coagulation system any further \[[@B17]\]. Pre- and postoperative platelet count and APTT were in our study without significant differences. The registered difference in the mean age between the groups must be without significant influence on the perioperative blood loss. We found no complications related to the brain or the heart during the hospital stay. In a recently published work, HEA demonstrates identical rates of cardiac and thromboembolic complications in elderly patients compared to normotensive epidural anaesthesia. Furthermore, there were no differences in early or long-term cognitive dysfunction \[[@B18]\]. None of the patients died in the perioperative period, in agreement with the very low mortality described by Sharrock \[[@B7]\].

Conclusions
===========

HEA is found to reduce the perioperative blood loss and the need for transfusion compared to conventional anaesthesia \[[@B9],[@B10]\], but the combination of HEA and ANH seems in this study to be without any further benefits regarding the blood loss and need for transfusion.
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